BBA
MRNA icon

Baader Bank Aktiengesellschaft’s Moderna MRNA Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,768
Closed -$242K – 454
2024
Q3 		$242K Sell
3,768
-366
-9% -$33.6K 0.01% 339
2024
Q2 		$471K Buy
4,134
+884
+27% +$112K 0.03% 266
2024
Q1 		$346K Sell
3,250
-1,137
-26% -$115K 0.02% 272
2023
Q4 		$407K Sell
4,387
-1,244
-22% -$105K 0.03% 229
2023
Q3 		$555K Buy
5,631
+2,381
+73% +$266K 0.04% 204
2023
Q2 		$395K Sell
3,250
-1,355
-29% -$181K 0.02% 262
2023
Q1 		$678K Sell
4,605
-7,478
-62% -$1.23M 0.03% 216
2022
Q4 		$2.17M Sell
12,083
-12,270
-50% -$2.01M 0.1% 145
2022
Q3 		$2.88M Sell
24,353
-182
-0.7% -$27.6K 0.19% 120
2022
Q2 		$3.5M Hold
24,535
– – 0.27% 95
2022
Q1 		$4.23M Sell
24,535
-2,126
-8% -$358K 0.34% 65
2021
Q4 		$6.77M Buy
+26,661
New +$7.8M 0.52% 53

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Baader Bank Aktiengesellschaft's MRNA Position: Q4 2024 in Review

Baader Bank Aktiengesellschaft sold out of Moderna (MRNA) in Q4 2024, closing a stake of 3,768 shares — an estimated $242K sold.

Baader Bank Aktiengesellschaft first reported a position in MRNA in Q4 2021 and held it in 12 quarters. The position peaked at $6.77M in Q4 2021. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Baader Bank Aktiengesellschaft reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 3,768 Moderna shares in Q4 2024, an estimated $242K.
  • Baader Bank Aktiengesellschaft first reported a position in Moderna in Q4 2021 and held it in 12 quarters.
  • Baader Bank Aktiengesellschaft's Moderna position peaked at $6.77M in Q4 2021.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2024, filed 23 Jan 2025.